UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Binary polymeric amorphous carvedilol solid dispersions: In vitro and in vivo characterization

European journal of pharmaceutical sciences, 2020-07, Vol.150, p.105343, Article 105343

2020

Volltextzugriff (PDF)

Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study

International journal of biological macromolecules, 2019-08, Vol.135, p.246-260

2019

Volltextzugriff (PDF)

Mitigation of Nitrogen Mustard-Induced Skin Injury by the β -Blocker Carvedilol and Its Enantiomers

The Journal of pharmacology and experimental therapeutics, 2024-02, Vol.388 (2), p.495-505

2024

Volltextzugriff (PDF)

The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo

Pharmacology, biochemistry and behavior, 2019-06, Vol.181, p.37-45

2019

Volltextzugriff (PDF)

Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells

Biomedicine & pharmacotherapy, 2018-12, Vol.108, p.1617-1627

2018

Volltextzugriff (PDF)

Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment

Clinical gastroenterology and hepatology, 2024-08

2024

Volltextzugriff (PDF)

Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients

European journal of cancer (1990), 2021-04, Vol.147, p.106-116

2021

Volltextzugriff (PDF)

Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity

European journal of pharmaceutical sciences, 2024-09, Vol.200, p.106849, Article 106849

2024

Volltextzugriff (PDF)

Hot melt-extrusion improves the properties of cyclodextrin-based poly(pseudo)rotaxanes for transdermal formulation

International journal of pharmaceutics, 2020-08, Vol.586, p.119510, Article 119510

2020

Volltextzugriff (PDF)

Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis

Toxicological sciences, 2023-11, Vol.196 (2), p.200-217

2023

Volltextzugriff (PDF)

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

Journal of hepatology, 2022-10, Vol.77 (4), p.1014-1025

2022

Volltextzugriff (PDF)

Preparation, Characterization, and Selection of Optimal Forms of (S)-Carvedilol Salts for the Development of Extended-Release Formulation

Molecular pharmaceutics, 2021-06, Vol.18 (6), p.2298-2310

2021

Volltextzugriff (PDF)

Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease

Journal of clinical pharmacology, 2020-01, Vol.60 (1), p.75-85

2020

Volltextzugriff (PDF)

The Impact of Carvedilol on Organ Index, Inflammatory Mediators, Oxidative Stress Parameters and Skin Markers in D-Galactose-Induced Aging Mice

INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY, 2023-09, Vol.13 (3), p.1017-1023

2023

Volltextzugriff (PDF)

Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol

Circulation (New York, N.Y.), 2023-11, Vol.148 (21), p.1691-1704

2023

Volltextzugriff (PDF)

Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway

Biochemical and biophysical research communications, 2023-01, Vol.639, p.150-160

2023

Volltextzugriff (PDF)

Design of ultra-fine carvedilol nanococrystals: Development of a safe and stable injectable formulation

European journal of pharmaceutics and biopharmaceutics, 2021-11, Vol.168, p.139-151

2021

Volltextzugriff (PDF)

Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer

Journal of the American College of Cardiology, 2019-06, Vol.73 (22), p.2859-2868

2019

Volltextzugriff (PDF)

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Cochrane database of systematic reviews, 2018-10, Vol.10 (10), p.CD011510

2018

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of a New Series of Carvedilol Derivatives That Protect Sensory Hair Cells from Aminoglycoside-Induced Damage by Blocking the Mechanoelectrical Transducer Channel

Journal of medicinal chemistry, 2019-06, Vol.62 (11), p.5312-5329

2019

Volltextzugriff (PDF)

A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis

American journal of kidney diseases, 2018-09, Vol.72 (3), p.337-348

2018

Volltextzugriff (PDF)

Development of Solid Dispersion by Hot Melt Extrusion Using Mixtures of Polyoxylglycerides With Polymers as Carriers for Increasing Dissolution Rate of a Poorly Soluble Drug Model

Journal of pharmaceutical sciences, 2019-02, Vol.108 (2), p.888-896

2019

Volltextzugriff (PDF)

Synergistic action of carvedilol and clomiphene in mitigating the behavioral phenotypes of letrozole-model of PCOS rats by modulating the NRF2/NFKB pathway

Life sciences (1973), 2023-07, Vol.324, p.121737-121737, Article 121737

2023

Volltextzugriff (PDF)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer's disease

Frontiers in pharmacology, 2022, Vol.13, p.1125890-1125890

2022

Volltextzugriff (PDF)

Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study

European journal of pharmacology, 2022-10, Vol.932, p.175204, Article 175204

2022

Volltextzugriff (PDF)

1 – 25 von 2.482

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.225)
Mit Volltextzugriff
(2.126)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Carvedilol
(2.242)
Science & Technology
(1.884)
Life Sciences & Biomedicine
(1.740)
Humans
(1.148)
Male
(878)
Pharmacology & Pharmacy
(684)
Cardiovascular System & Cardiology
(651)
Carbazoles - Therapeutic Use
(635)
Propanolamines - Therapeutic Use
(626)
Female
(599)
Adrenergic Beta-Antagonists - Therapeutic Use
(587)
Cardiac & Cardiovascular Systems
(583)
Animals
(528)
Biological And Medical Sciences
(527)
Medical Sciences
(500)
Middle Aged
(477)
Carbazoles - Pharmacology
(426)
Heart Failure
(417)
Propanolamines - Pharmacology
(409)
Pharmacology. Drug Treatments
(393)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.641)
IngentaConnect
(1.361)
EZB Electronic Journals Library
(1.218)
Journals@Ovid Full Text
(979)
IngentaConnect Journals
(698)
Elsevier ScienceDirect Journals Collection
(543)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(433)
SpringerLink
(274)
Wiley Online Library Journals
(261)
Publisher or Other Site
(196)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(192)
Wiley Online Library Full Collection 2018
(182)
Taylor & Francis Journals Auto-Holdings Collection
(139)
Taylor & Francis
(126)
Taylor & Francis:Master (3349 titles)
(109)
Oxford journals
(101)
Oxford Journals 2020 Medicine
(84)
Nexis Uni
(57)
Sage Journals
(49)
BMJ Journals
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Binary polymeric amorphous carvedilol solid dispersions: In vitro and in vivo characterization

Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study

Mitigation of Nitrogen Mustard-Induced Skin Injury by the β -Blocker Carvedilol and Its Enantiomers

The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo

Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells

Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment

Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients

Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity

Hot melt-extrusion improves the properties of cyclodextrin-based poly(pseudo)rotaxanes for transdermal formulation

Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

Preparation, Characterization, and Selection of Optimal Forms of (S)-Carvedilol Salts for the Development of Extended-Release Formulation

Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease

The Impact of Carvedilol on Organ Index, Inflammatory Mediators, Oxidative Stress Parameters and Skin Markers in D-Galactose-Induced Aging Mice

Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol

Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway

Design of ultra-fine carvedilol nanococrystals: Development of a safe and stable injectable formulation

Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Design, Synthesis, and Biological Evaluation of a New Series of Carvedilol Derivatives That Protect Sensory Hair Cells from Aminoglycoside-Induced Damage by Blocking the Mechanoelectrical Transducer Channel

A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis

Development of Solid Dispersion by Hot Melt Extrusion Using Mixtures of Polyoxylglycerides With Polymers as Carriers for Increasing Dissolution Rate of a Poorly Soluble Drug Model

Synergistic action of carvedilol and clomiphene in mitigating the behavioral phenotypes of letrozole-model of PCOS rats by modulating the NRF2/NFKB pathway

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer's disease

Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study

Suchergebnisse filtern